Form EFFECT NERVGEN PHARMA CORP.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 26, 2026 4:00 P.M. |
| Form: | F-10 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Let America Build™ Campaign Comes to Boston to Spotlight America's Growing Housing Supply Gap
- Monogoto Receives 2026 IoT Evolution Product of the Year Award for the Second Consecutive Year
- Lexitas Sweeps New York Law Journal’s 2026 “Best Of” Awards with 14 First Place Honors for Litigation Support
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
